Treatment for glioblastoma (GBM)
Intended for US audiences only.
Optune® Novocure™

Educational resources

Print or download these materials to become more familiar with Optune and to help introduce Optune to your healthcare team, family, and others who are involved in your treatment.

You will notice that some materials are specific to whether you have newly diagnosed or recurrent GBM, while other materials are not specific to a diagnosis.

General resources

Instructions For Use
A closer look at Optune benefits and safety information.
View this PDF
Patient Information and Operation Manual
Step-by-step directions for using all system components.
View this PDF
nCompass support brochure
Step-by-step directions for using all system components.
View this PDF
First glance at Optune
A brief look at life with Optune.
View this PDF
Understanding Optune
A resource for treatment-related questions.
View this PDF
Patient Scalp Care Guidelines
An educational guide which answers questions about scalp care and transducer array placement.
View this PDF
Travel Support by nCompass™ brochure
An overview of nCompass travel support offered before, during, and after your trip.
View this PDF

Would you like to contact a Novocure representative?


Contact us

Daily life with Optune

What you need to know about incorporating Optune into your daily life.

Learn more
Find a Treatment Center

OPT-041.6-23


CONTACT AN OPTUNE EXPERT

Indications For Use

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).

Optune with temozolomide is indicated for the treatment of adult patients with newly diagnosed, supratentorial glioblastoma following maximal debulking surgery and completion of radiation therapy together with concomitant standard of care chemotherapy.

For the treatment of recurrent GBM, Optune is indicated following histologically-or radiologically-confirmed recurrence in the supratentorial region of the brain after receiving chemotherapy. The device is intended to be used as a monotherapy, and is intended as an alternative to standard medical therapy for GBM after surgical and radiation options have been exhausted.

Important Safety Information

Contraindications

Do not use Optune if you have an active implanted medical device, a skull defect (such as, missing bone with no replacement), or bullet fragments. Use of Optune together with implanted electronic devices has not been tested and may theoretically lead to malfunctioning of the implanted device. Use of Optune together with skull defects or bullet fragments has not been tested and may possibly lead to tissue damage or render Optune ineffective.

Do not use Optune if you are known to be sensitive to conductive hydrogels. In this case, skin contact with the gel used with Optune may commonly cause increased redness and itching, and rarely may even lead to severe allergic reactions such as shock and respiratory failure.

Warnings and Precautions

Use Optune only after receiving training from qualified personnel, such as your doctor, a nurse, or other medical personnel who have completed a training course given by Novocure (the device manufacturer).

Do not use Optune if you are pregnant, you think you might be pregnant or are trying to get pregnant. It is not known if Optune is safe or effective in these populations.

The most common (≥10%) adverse events involving Optune in combination with temozolomide were low blood platelet count, nausea, constipation, vomiting, fatigue, scalp irritation from device use, headache, convulsions, and depression.

The most common (≥10%) adverse events seen when using Optune alone were scalp irritation from device use and headache.

The following adverse reactions were considered related to Optune when using the device alone: scalp irritation from device use, headache, malaise, muscle twitching, fall and skin ulcer.

All servicing procedures must be performed by qualified and trained personnel.

Do not use any parts that do not come with the Optune Treatment Kit, or that were not sent to you by the device manufacturer or given to you by your doctor.

Do not wet the device or transducer arrays.

If you have an underlying serious skin condition on the scalp, discuss with your doctor whether this may prevent or temporarily interfere with Optune treatment.


Please click here to see the Optune Instructions For Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

Patient Journey videos on this site depict actual patients and caregivers. All other depictions of patients, caregivers, and healthcare professionals are actor portrayals.

Indications For Use

Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).